Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
DENTSPLY SIRONA ( (XRAY) ) just unveiled an announcement.
On June 3, 2025, DENTSPLY SIRONA Inc. secured consent from its lenders to amend its revolving credit facility and entered into several agreements to adjust financial covenants and debt management strategies. These amendments, including a new financial covenant and leverage ratio adjustments, aim to enhance financial flexibility and manage interest rate risks, potentially impacting the company’s financial operations and stakeholder interests.
The most recent analyst rating on (XRAY) stock is a Hold with a $30.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
The overall stock score is primarily impacted by the company’s financial difficulties, including negative margins and a negative P/E ratio. While technical analysis and recent corporate events provide some positive aspects, the overall sentiment is cautious due to ongoing profitability challenges and operational risks. The company’s strategic initiatives and cash flow management offer some stability and future potential, but significant improvements in financial performance are needed to enhance investor confidence.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
DENTSPLY SIRONA Inc. operates in the dental industry, providing dental products and technologies, including dental equipment and consumables, to dental professionals and laboratories worldwide.
Average Trading Volume: 3,232,839
Technical Sentiment Signal: Sell
Current Market Cap: $3.11B
See more data about XRAY stock on TipRanks’ Stock Analysis page.